hydration effects glp-1 receptor agonists weight loss Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of Glucagon-like peptide 1(GLP-1) receptor agonists
Pay in 4 interest-free payments of $6.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
![hydration effects glp-1 receptor agonists weight loss Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of Glucagon-like peptide 1(GLP-1) receptor agonists](https://static.elsevier.es/multimedia/20132514/0000004300000004/v3_202505300603/S2013251423001475/v3_202505300603/en/main.assets/gr1.jpeg)
![hydration effects glp-1 receptor agonists weight loss Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of Glucagon-like peptide 1(GLP-1) receptor agonists](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8568/11144546/6a9030251bad/nihms-1989079-f0001.jpg)
![hydration effects glp-1 receptor agonists weight loss Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of Glucagon-like peptide 1(GLP-1) receptor agonists](https://www.cell.com/cms/10.1016/j.xcrm.2026.102665/asset/c4e5afac-f2d9-4476-9558-e963e21f2736/main.assets/fx1_lrg.jpg)
![hydration effects glp-1 receptor agonists weight loss Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of Glucagon-like peptide 1(GLP-1) receptor agonists](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13668-025-00649-w/MediaObjects/13668_2025_649_Fig1_HTML.png)
![hydration effects glp-1 receptor agonists weight loss Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of Glucagon-like peptide 1(GLP-1) receptor agonists](https://www.mdpi.com/jcm/jcm-15-02944/article_deploy/html/images/jcm-15-02944-g001.png)
























